A critical assessment of boron neutron capture therapy: an overview Rolf F. Barth OriginalPaper Pages: 1 - 5
Fission reactor neutron sources for neutron capture therapy — a critical review Otto K. HarlingKent J. Riley OriginalPaper Pages: 7 - 17
Accelerator-based epithermal neutron sources for boron neutron capture therapy of brain tumors Thomas E. BlueJacquelyn C. Yanch OriginalPaper Pages: 19 - 31
A critical assessment of boron target compounds for boron neutron capture therapy M. Frederick HawthorneMark W. Lee OriginalPaper Pages: 33 - 45
Ligand liposomes and boron neutron capture therapy Jörgen CarlssonErika Bohl KullbergLars Gedda OriginalPaper Pages: 47 - 59
Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation Rolf F. BarthWeilian YangJeffrey A. Coderre OriginalPaper Pages: 61 - 74
Computational dosimetry and treatment planning considerations for neutron capture therapy David W. Nigg OriginalPaper Pages: 75 - 86
Clinical review of the japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams Yoshinobu NakagawaKyonghon PoohHiroaki Kumada OriginalPaper Pages: 87 - 99
Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician’s point of view Aidnag Z. Diaz OriginalPaper Pages: 101 - 109
A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease Paul M. BusseOtto K. HarlingRobert G. Zamenhof OriginalPaper Pages: 111 - 121
Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronophenylalanine Heikki JoensuuLeena KankaanrantaSauli Savolainen OriginalPaper Pages: 123 - 134
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden Jacek CapalaBritta H.-StenstamRoger Henriksson OriginalPaper Pages: 135 - 144
Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial Katalin HideghétyWolfgang SauerweinDetlef Gabel OriginalPaper Pages: 145 - 156
Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy Christopher R. GibsonAlfred E. StaubusMelvin M. Moeschberger OriginalPaper Pages: 157 - 169
Pharamacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy:10B concentration predictions and dosimetric consequences W. S. KigerM. R. PalmerP. M. Busse OriginalPaper Pages: 171 - 186
The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma George W. KabalkaTrent L. NicholsPaul M. Busse OriginalPaper Pages: 187 - 195
Common challenges and problems in clinical trials of boron neutron capture therapy of brain tumors N. GuptaR. A. GahbauerB. Albertson OriginalPaper Pages: 197 - 210